Name | Number of supported studies | Average coverage | |
---|---|---|---|
interneuron | 4 studies | 29% ± 15% | |
endothelial cell of lymphatic vessel | 3 studies | 23% ± 8% | |
GABAergic neuron | 3 studies | 23% ± 5% | |
astrocyte | 3 studies | 18% ± 3% | |
glutamatergic neuron | 3 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 21% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 850.15 | 241 / 245 | 96% | 5.81 | 483 / 502 |
thymus | 100% | 361.38 | 652 / 653 | 86% | 3.23 | 518 / 605 |
breast | 88% | 138.28 | 405 / 459 | 96% | 9.30 | 1069 / 1118 |
lung | 91% | 188.47 | 526 / 578 | 90% | 4.87 | 1037 / 1155 |
bladder | 100% | 691.81 | 21 / 21 | 71% | 3.53 | 359 / 504 |
uterus | 89% | 317.48 | 152 / 170 | 73% | 5.35 | 336 / 459 |
adrenal gland | 79% | 94.19 | 204 / 258 | 62% | 2.23 | 143 / 230 |
skin | 78% | 332.17 | 1411 / 1809 | 59% | 3.50 | 277 / 472 |
intestine | 71% | 134.54 | 688 / 966 | 62% | 2.40 | 326 / 527 |
esophagus | 62% | 87.86 | 903 / 1445 | 69% | 2.24 | 126 / 183 |
ovary | 74% | 147.07 | 134 / 180 | 52% | 1.32 | 222 / 430 |
kidney | 58% | 67.10 | 52 / 89 | 63% | 4.38 | 566 / 901 |
stomach | 36% | 40.45 | 131 / 359 | 70% | 2.90 | 201 / 286 |
pancreas | 14% | 13.09 | 47 / 328 | 92% | 8.36 | 164 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.11 | 1 / 1 |
blood vessel | 98% | 499.78 | 1308 / 1335 | 0% | 0 | 0 / 0 |
adipose | 88% | 180.57 | 1059 / 1204 | 0% | 0 | 0 / 0 |
liver | 42% | 41.75 | 96 / 226 | 23% | 0.56 | 92 / 406 |
tonsil | 0% | 0 | 0 / 0 | 47% | 2.11 | 21 / 45 |
brain | 24% | 36.30 | 642 / 2642 | 15% | 0.42 | 107 / 705 |
eye | 0% | 0 | 0 / 0 | 39% | 1.00 | 31 / 80 |
lymph node | 0% | 0 | 0 / 0 | 34% | 1.05 | 10 / 29 |
heart | 23% | 31.63 | 199 / 861 | 0% | 0 | 0 / 0 |
spleen | 10% | 6.84 | 25 / 241 | 0% | 0 | 0 / 0 |
muscle | 9% | 9.52 | 74 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.73 | 11 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018401 | Biological process | peptidyl-proline hydroxylation to 4-hydroxy-L-proline |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005506 | Molecular function | iron ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0031418 | Molecular function | L-ascorbic acid binding |
GO_0004656 | Molecular function | procollagen-proline 4-dioxygenase activity |
Gene name | P4HA3 |
Protein name | Prolyl 4-hydroxylase subunit alpha-3 (4-PH alpha-3) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3) Prolyl 4-hydroxylase subunit alpha 3 |
Synonyms | UNQ711/PRO1374 |
Description | FUNCTION: Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins. . |
Accessions | Q7Z4N8 ENST00000427714.2 [Q7Z4N8-3] H0YCC3 ENST00000525968.1 ENST00000524388.5 [Q7Z4N8-2] ENST00000532689.6 E9PM97 ENST00000331597.9 [Q7Z4N8-1] |